EFDID: 68381EFD: View Filing

Issuer: Cahaba Pharmaceuticals, LLC (0001460300) - D

Accession: 0001460300-13-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001460300
  • Entity Name:
    Cahaba Pharmaceuticals, LLC
  • Entity Type:
    Limited Liability Company
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2008)
  • Address:
    103 Carnegie Center
    Suite 300
    Princeton, NJ 08540
  • Persons:
    Related Persons 3
    Andrew P. Aromando
    Executive Officer
    J. Rainer Twiford
    Executive OfficerDirector
    Madding King, III
    Executive OfficerDirector
EDGAR: Offering Information
  • Accession Date:
    01/18/2013
  • First Sale Date:
    01/09/2013
  • Offering Amount:
    $1,000,000
  • Amount Sold:
    $205,000
  • Amount Remaining:
    $795,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Debt
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Julio A. Marquez 2261430 Gottbetter Capital Markets, LLC 20680 AL, CA, CO, FL, IN, MN, TN
Stephen Renaud 1476612 Gottbetter Capital Markets, LLC 20680 AL, CA, CO, FL, IN, MN, TX
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Cahaba Pharmaceuticals, LLCAndrew P. AromandoAndrew P. AromandoChief Executive Officer2013-01-18